A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
allergic 13 21 13 21 O
reactions 22 31 22 31 O
attributed 32 42 32 42 O
to 43 45 43 45 O
compounds 46 55 46 55 B-allergy_name
of 56 58 56 58 I-allergy_name
similar 59 66 59 66 I-allergy_name
chemical 67 75 67 75 I-allergy_name
or 76 78 76 78 I-allergy_name
biologic 79 87 79 87 I-allergy_name
composition 88 99 88 99 I-allergy_name
to 100 102 100 102 I-allergy_name
palbociclib 103 114 103 114 I-allergy_name
, 114 115 114 115 O
letrozole 116 125 116 125 B-allergy_name
, 125 126 125 126 O
trastuzumab 127 138 127 138 B-allergy_name
, 138 139 138 139 O
any 140 143 140 143 O
other 144 149 144 149 O
aromatase 150 159 150 159 B-allergy_name
inhibitor 160 169 160 169 I-allergy_name
, 169 170 169 170 O
any 171 174 171 174 O
other 175 180 175 180 O
monoclonal 181 191 181 191 B-allergy_name
antibody 192 200 192 200 I-allergy_name
, 200 201 200 201 O
or 202 204 202 204 O
other 205 210 205 210 B-allergy_name
agents 211 217 211 217 I-allergy_name
used 218 222 218 222 I-allergy_name
in 223 225 223 225 I-allergy_name
the 226 229 226 229 I-allergy_name
study 230 235 230 235 I-allergy_name

AST(SGOT)/ALT(SGPT 0 18 236 254 B-clinical_variable
) 18 19 254 255 I-clinical_variable
≤ 20 21 256 257 O
2.5 22 25 258 261 B-upper_bound
x 26 27 262 263 I-upper_bound
IULN 28 32 264 268 I-upper_bound

Absolute 0 8 269 277 B-clinical_variable
neutrophil 9 19 278 288 I-clinical_variable
count 20 25 289 294 I-clinical_variable
≥ 26 27 295 296 O
1,500 28 33 297 302 B-lower_bound
/ 33 34 302 303 I-lower_bound
mcl 34 37 303 306 I-lower_bound

At 0 2 307 309 O
least 3 8 310 315 O
18 9 11 316 318 B-lower_bound
years 12 17 319 324 I-lower_bound
of 18 20 325 327 O
age 21 24 328 331 B-age

Baseline 0 8 332 340 B-clinical_variable
corrected 9 18 341 350 I-clinical_variable
QT 19 21 351 353 I-clinical_variable
interval 22 30 354 362 I-clinical_variable
( 31 32 363 364 I-clinical_variable
QTcF 32 36 364 368 I-clinical_variable
) 36 37 368 369 I-clinical_variable
< 38 39 370 371 O
480 40 43 372 375 B-upper_bound
ms 44 46 376 378 I-upper_bound

Eastern 0 7 379 386 B-clinical_variable
Cooperative 8 19 387 398 I-clinical_variable
Oncology 20 28 399 407 I-clinical_variable
Group 29 34 408 413 I-clinical_variable
( 35 36 414 415 I-clinical_variable
ECOG 36 40 415 419 I-clinical_variable
) 40 41 419 420 I-clinical_variable
performance 42 53 421 432 I-clinical_variable
status 54 60 433 439 I-clinical_variable
≤ 61 62 440 441 O
1 63 64 442 443 B-upper_bound

Indeterminate 0 13 444 457 O
or 14 16 458 460 O
negative 17 25 461 469 O
HER2 26 30 470 474 B-clinical_variable
status 31 37 475 481 I-clinical_variable

Inflammatory 0 12 482 494 B-cancer
breast 13 19 495 501 I-cancer
cancer 20 26 502 508 I-cancer

Known 0 5 509 514 O
hepatitis 6 15 515 524 B-chronic_disease
B 16 17 525 526 I-chronic_disease
or 18 20 527 529 I-chronic_disease
C 21 22 530 531 I-chronic_disease
infection 23 32 532 541 I-chronic_disease

Left 0 4 542 546 B-clinical_variable
ventricular 5 16 547 558 I-clinical_variable
ejection 17 25 559 567 I-clinical_variable
fraction 26 34 568 576 I-clinical_variable
( 35 36 577 578 I-clinical_variable
LVEF 36 40 578 582 I-clinical_variable
) 40 41 582 583 I-clinical_variable
≥ 42 43 584 585 O
50 44 46 586 588 B-lower_bound
% 46 47 588 589 I-lower_bound
by 48 50 590 592 O
transthoracic 51 64 593 606 B-treatment
echocardiogram 65 79 607 621 I-treatment
or 80 82 622 624 O
multigated 83 93 625 635 B-treatment
acquisition 94 105 636 647 I-treatment
scan 106 110 648 652 I-treatment
( 111 112 653 654 I-treatment
MUGA 112 116 654 658 I-treatment
) 116 117 658 659 I-treatment

Leukocytes 0 10 660 670 B-clinical_variable
≥ 11 12 671 672 O
3,000 13 18 673 678 B-lower_bound
/ 18 19 678 679 I-lower_bound
mcL 19 22 679 682 I-lower_bound

Patients 0 8 683 691 O
with 9 13 692 696 O
histologically 14 28 697 711 O
confirmed 29 38 712 721 O
palpable 39 47 722 730 O
lymph 48 53 731 736 O
nodes 54 59 737 742 O
may 60 63 743 746 O
be 64 66 747 749 O
enrolled 67 75 750 758 O
regardless 76 86 759 769 O
of 87 89 770 772 O
breast 90 96 773 779 B-cancer
tumor 97 102 780 785 I-cancer
size 103 107 786 790 O

Platelets 0 9 791 800 B-clinical_variable
≥ 10 11 801 802 O
100,000 12 19 803 810 B-lower_bound
/ 19 20 810 811 I-lower_bound
mcl 20 23 811 814 I-lower_bound

Pregnant 0 8 815 823 B-pregnancy

Tumor 0 5 824 829 B-clinical_variable
size 6 10 830 834 I-clinical_variable
at 11 13 835 837 O
least 14 19 838 843 O
2 20 21 844 845 B-lower_bound
cm 22 24 846 848 I-lower_bound
in 25 27 849 851 O
one 28 31 852 855 O
dimension 32 41 856 865 O
by 42 44 866 868 O
clinical 45 53 869 877 O
or 54 56 878 880 O
radiographic 57 69 881 893 O
exam 70 74 894 898 O
( 75 76 899 900 O
World 76 81 900 905 O
Health 82 88 906 912 O
Organization 89 101 913 925 O
( 102 103 926 927 O
WHO 103 106 927 930 O
) 106 107 930 931 O
criteria 108 116 932 940 O
) 116 117 940 941 O

Uncontrolled 0 12 942 954 O
intercurrent 13 25 955 967 O
illness 26 33 968 975 O
including 34 43 976 985 O
, 43 44 985 986 O
but 45 48 987 990 O
not 49 52 991 994 O
limited 53 60 995 1002 O
to 61 63 1003 1005 O
, 63 64 1005 1006 O
ongoing 65 72 1007 1014 B-chronic_disease
or 73 75 1015 1017 I-chronic_disease
active 76 82 1018 1024 I-chronic_disease
infection 83 92 1025 1034 I-chronic_disease
, 92 93 1034 1035 O
symptomatic 94 105 1036 1047 B-chronic_disease
congestive 106 116 1048 1058 I-chronic_disease
heart 117 122 1059 1064 I-chronic_disease
failure 123 130 1065 1072 I-chronic_disease
, 130 131 1072 1073 O
unstable 132 140 1074 1082 B-chronic_disease
angina 141 147 1083 1089 I-chronic_disease
pectoris 148 156 1090 1098 I-chronic_disease
, 156 157 1098 1099 O
or 158 160 1100 1102 O
cardiac 161 168 1103 1110 B-chronic_disease
arrhythmia 169 179 1111 1121 I-chronic_disease

Women 0 5 1122 1127 B-gender
of 6 8 1128 1130 O
childbearing 9 21 1131 1143 O
potential 22 31 1144 1153 O
must 32 36 1154 1158 O
agree 37 42 1159 1164 O
to 43 45 1165 1167 O
undergo 46 53 1168 1175 O
pregnancy 54 63 1176 1185 O
testing 64 71 1186 1193 O
within 72 78 1194 1200 O
14 79 81 1201 1203 B-upper_bound
days 82 86 1204 1208 I-upper_bound
of 87 89 1209 1211 O
study 90 95 1212 1217 O
entry 96 101 1218 1223 O
and 102 105 1224 1227 O
agree 106 111 1228 1233 B-contraception_consent
to 112 114 1234 1236 I-contraception_consent
use 115 118 1237 1240 I-contraception_consent
adequate 119 127 1241 1249 I-contraception_consent
contraception 128 141 1250 1263 I-contraception_consent
( 142 143 1264 1265 O
barrier 143 150 1265 1272 O
method 151 157 1273 1279 O
of 158 160 1280 1282 O
birth 161 166 1283 1288 O
control 167 174 1289 1296 O
, 174 175 1296 1297 O
abstinence 176 186 1298 1308 O
, 186 187 1308 1309 O
not 188 191 1310 1313 O
hormonal 192 200 1314 1322 O
) 200 201 1322 1323 O
prior 202 207 1324 1329 O
to 208 210 1330 1332 O
study 211 216 1333 1338 O
entry 217 222 1339 1344 O
and 223 226 1345 1348 O
for 227 230 1349 1352 O
the 231 234 1353 1356 O
duration 235 243 1357 1365 O
of 244 246 1366 1368 O
study 247 252 1369 1374 O
participation 253 266 1375 1388 O
as 267 269 1389 1391 O
well 270 274 1392 1396 O
as 275 277 1397 1399 O
chemical 278 286 1400 1408 O
LHRH 287 291 1409 1413 O
Agonist 292 299 1414 1421 O
with 300 304 1422 1426 O
goserelin 305 314 1427 1436 O

Women 0 5 1437 1442 B-gender
of 6 8 1443 1445 O
childbearing 9 21 1446 1458 O
potential 22 31 1459 1468 O
must 32 36 1469 1473 O
have 37 41 1474 1478 O
a 42 43 1479 1480 O
negative 44 52 1481 1489 B-pregnancy
pregnancy 53 62 1490 1499 I-pregnancy
test 63 67 1500 1504 O
within 68 74 1505 1511 O
14 75 77 1512 1514 B-upper_bound
days 78 82 1515 1519 I-upper_bound
of 83 85 1520 1522 O
study 86 91 1523 1528 O
entry 92 97 1529 1534 O

